Product Description

To reduce the development of drug resistant bacteria and maintain the effectiveness of amoxycillin/clavulanate potassium and other antibacterial drugs, amoxycillin/clavulanic acid should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
EXMOCLAV- 625 is a combination penicillin-class antibacterial and beta-lactamase inhibitor indicated in the treatment of infections due to susceptible isolates of the designated bacteria in the conditions listed below*
• Lower Respiratory Tract Infections caused by betalactamase-producing isolates of Haemophilusinfluenzae and Moraxella catarrhalis.
• Acute Bacterial Otitis Media caused by betalactamase-producing isolates of H. influenzae and M. catarrhalis.
• Sinusitis caused by betalactamase-producing isolates of H. influenzae and M. catarrhalis.
• Skin and Skin Structure Infections caused by betalactamase-producing isolates of Staphylococcus aureus, Escherichia coli, and Klebsiella species.
• Urinary Tract Infections caused by betalactamase-producing isolates of E. coli, Klebsiella species, and Enterobacter species.
• Bone and joint infections
• Other infections e.g.intra-abdominal sepsis and dental infections.

How to use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it

Uses

Treatment of Bacterial Infections

Side Effects

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

• Vomiting
• Nausea
• Diarrhea

Storage

Store below 30℃